MARKET

LFSC

LFSC

F/m Emerald Life Sciences Innovation ETF
NASDAQ
38.36
-0.08
-0.20%
After Hours: 38.36 0 0.00% 16:10 05/12 EDT
OPEN
38.36
PREV CLOSE
38.44
HIGH
38.46
LOW
38.17
VOLUME
1.35K
TURNOVER
--
52 WEEK HIGH
40.10
52 WEEK LOW
22.53
TOTAL ASSET
102.50M
YTD YIELD
69.52%
1D
5D
1M
3M
1Y
5Y
1D
Spyre Therapeutics Breaks Higher On Positive Data From Ulcerative Colitis Drug
Benzinga · 04/13 17:29
Cogent Biosciences Stock Climbs After FDA Accepts Key Drug Application
Benzinga · 03/16 16:42
FDA Approves Guardant Health's Blood Test To Guide Treatment For Advanced Colorectal Cancer
Benzinga · 01/22 17:51
Travere Stock Slips After FDA Delays Review Of Key Kidney Drug
Benzinga · 01/14 11:44
Best-Performing Active ETFs of 2025
NASDAQ · 12/31/2025 16:00
This New ETF Doesn't Wait For Stability — It Profits From Disruption
Benzinga · 10/14/2025 22:50
Weekly Report: what happened at LFSC last week (0908-0912)?
Weekly Report · 09/15/2025 12:25
Weekly Report: what happened at LFSC last week (0901-0905)?
Weekly Report · 09/08/2025 12:27
More
Profile
Fund Name
F/m Emerald Life Sciences Innovation ETF
Inception Date
2024-10-30
Benchmark
MSCI ACWI NR USD
Advisor Company
Emerald Mutual Fund Advisers Trust
Custodian
U.S. Bank N.A
Manager
Joseph Garner, Stacey Sears, Nishit Trivedi, Terry M. Smith, Kenneth Mertz